Finance

Beta
Lists
COYA:NASDAQ
Coya Therapeutics Inc
US$ ५.८६
+३.५३%
(+०.२०) 1D
US$ ५.८६
०.००% (०.००)
After hours
Closed: जुलाई २, १६:००:०१ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for COYA...
Open
US$ ५.७५
High
US$ ६.१०
Low
US$ ५.५७
Mkt. cap
१३.७५ करोड
Avg. vol.
१.७१ लाख
Volume
१.०७ लाख
52-wk high
US$ ७.७५
52-wk low
US$ ३.७१
EPS
-US$ १.१५
Beta
०.५१
Shares outstanding
२.३५ करोड
No. of employees
Open
US$ ५.७५
High
US$ ६.१०
Low
US$ ५.५७
Mkt. cap
१३.७५ करोड
Avg. vol.
१.७१ लाख
Volume
१.०७ लाख
52-wk high
US$ ७.७५
52-wk low
US$ ३.७१
EPS
-US$ १.१५
Beta
०.५१
Shares outstanding
२.३५ करोड
No. of employees
News stories
From sources across the web
About Coya Therapeutics Inc
CEO-
Employees
Founded२०२०
Headquartersह्युस्टन, टेक्सस, संयुक्त राज्य अमेरिका
Sector-
Analyst ratings
Based on 4 analysts giving stock ratings to COYA in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for COYA in the last 3 months.
Highest
Current US$ ५.८६
US$ १८.०० (+२०७.१७%)
Average
US$ १५.२५ (+१६०.२४%)
Lowest
US$ १२.०० (+१०४.७८%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
US$ १८.००
+२०७.२%
06/25/2026
Boobalan Pachaiyappan
Roth MKM
Buy
Initiated
US$ १२.००
+१०४.८%
06/05/2026
Chad Messer
Lake Street
Buy
Maintained
US$ १७.००
+१९०.१%
05/22/2026
Keay Nakae
Chardan Capital
Buy
Maintained
US$ १४.००
+१३८.९%
05/12/2026
Thomas Shrader
BTIG
Buy
Maintained
US$ १६.००
+१७३%
03/16/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
२०२५ जुन
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
Revenue
१.६४ लाख
३५.६४ लाख
३९.६० लाख
२.५१ लाख
Cost of goods sold
३६.६३ लाख
२९.१७ लाख
४९.४० लाख
४०.९७ लाख
Cost of revenue
३६.६३ लाख
२९.१७ लाख
४९.४० लाख
४०.९७ लाख
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
२९.०८ लाख
२५.५७ लाख
३२.७० लाख
३७.८२ लाख
Operating expense
२९.१५ लाख
२५.६४ लाख
३२.७७ लाख
३७.८५ लाख
Total operating expenses
६५.७८ लाख
५४.८१ लाख
८२.१७ लाख
७८.८१ लाख
Operating income
-६४.१५ लाख
-१९.१७ लाख
-४२.५७ लाख
-७६.३० लाख
Other non operating income
-
-
-
-
EBT including unusual items
-६०.९५ लाख
-२१.१६ लाख
-५७.०५ लाख
-७२.०७ लाख
EBT excluding unusual items
-६०.९५ लाख
-१६.०० लाख
-३९.३२ लाख
-७१.९७ लाख
Income tax expense
-
-
३.०९ हजार
-
Effective tax rate
-
-
-०.०५%
-
Other operating expenses
-
-
-
-
Net income
-६०.९५ लाख
-२१.१६ लाख
-५७.०९ लाख
-७२.०७ लाख
Net profit margin
-३,७२५.१७%
-५९.३६%
-१४४.१६%
-२,८६९.६३%
Earnings per share
-०.३६
-०.१३
-०.३४
-०.३२
Interest and investment income
३.२० लाख
३.१७ लाख
३.२५ लाख
४.३३ लाख
Interest expense
-
-
-
-
Net interest expenses
३.२० लाख
३.१७ लाख
३.२५ लाख
४.३३ लाख
Depreciation and amortization charges
६.८४ हजार
६.८४ हजार
६.८४ हजार
२.८१ हजार
EBITDA
-६४.०८ लाख
-१९.१० लाख
-४२.५० लाख
-७६.२७ लाख
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a task
Deep Search
AI content may include mistakes. Learn more